Tenax Therapeutics Inc (NASDAQ:TENX) price on Thursday, March 28, rose 9.56% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $4.24.
A look at the stock’s price movement, the close in the last trading session was $3.87. The beta value (5-Year monthly) was 2.28. Turning to its 52-week performance, $61.20 and $3.48 were the 52-week high and 52-week low respectively. Overall, TENX moved 2.42% over the past month.
Tenax Therapeutics Inc’s market cap currently stands at around $7.50 million, with investors looking forward to this quarter’s earnings report slated for May 13, 2024 – May 17, 2024. Analysts project the company’s earnings per share (EPS) to be -$8.14, which has seen fiscal year 2023 EPS growth forecast to increase to -$28.8 and about -$6.33 for fiscal year 2024. Per the data, EPS growth is expected to be 95.20% for 2024 and 78.00% for the next financial year.
Revisions could be used as tool to get short term price movement insight, and for the company that in the past seven days was no upward and no downward review(s). Turning to the stock’s technical picture we see that short term indicators suggest on average that TENX is a 50% Sell. On the other hand, the stock is on average a 100% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
TENX’s current price about 4.29% and -32.65% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 43.49, while 7-day volatility ratio is 7.27% and 8.20% in the 30-day chart. Further, Tenax Therapeutics Inc (TENX) has a beta value of 2.23, and an average true range (ATR) of 0.57.
If we refocus on Tenax Therapeutics Inc (NASDAQ:TENX), historical trading data shows that trading volumes averaged 62130.0 over the past 10 days and 349.90K over the past 3 months.
The 4.44% of Tenax Therapeutics Inc’s shares are in the hands of company insiders while institutional holders own 19.54% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 36720.0 on Mar 15, 2024, giving us a short ratio of 0.16. The data shows that as of Mar 15, 2024 short interest in Tenax Therapeutics Inc (TENX) stood at 2.08% of shares outstanding, with shares short falling to 46390.0 registered in Feb 15, 2024. Current price change has pushed the stock -80.70% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the TENX stock continues to rise going into the next quarter.
